Company intelligence

Beeline Medicine

BiotechActive

Is this your company? Get featured or correct your listing →

Suggest a correction

We're still building this profile — here is what Pulse has covered.

Latest Pulse

  1. Biotech VCs Are Betting Big on Single Clinical TrialsCelea Therapeutics' $180M round, Beeline Medicine's $126.3M raise and Flare Therapeutics' $85M financing show late-stage biotech investors concentrating capital into single, high-conviction trial bets rather than diversified platform plays.→

Coverage Timeline

newest first
  1. Jul 5, 2026FUNDINGBiotech VCs Are Betting Big on Single Clinical Trials$391M+ combined across 3 single-trial bets→

All Coverage

FUNDING

Biotech VCs Are Betting Big on Single Clinical Trials

Illustration for: Biotech VCs Are Betting Big on Single Clinical Trials
FUNDING$391M+ combined across 3 single-trial bets

Biotech VCs Are Betting Big on Single Clinical Trials

Celea Therapeutics' $180M round, Beeline Medicine's $126.3M raise and Flare Therapeutics' $85M financing show late-stage biotech investors concentrating capital into single, high-conviction trial bets rather than diversified platform plays.

Related Companies

Same sector
Scribe TherapeuticsAttovia TherapeuticsIambic TherapeuticsApnimedRetension PharmaceuticalsEli Lilly